SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000910680-19-000040
Filing Date
2019-06-05
Accepted
2019-06-05 16:25:12
Documents
6
Period of Report
2019-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k-05302019.htm 8-K 42725
2 DIVIS - 2019 AMENDED EMPLOYMENT AGREEMENT ex10_1-f8k05302019.htm EX-10.1 119589
3 DUBOW - 2019 EMPLOYMENT AGREEMENT ex10_2-f8k05302019.htm EX-10.2 110872
4 PRESS RELEASE DATED JUNE 3, 2019 ex99_1-f8k06032019.htm EX-99.1 11030
5 image00001.jpg GRAPHIC 3872
6 image00002.jpg GRAPHIC 2823
  Complete submission text file 0000910680-19-000040.txt   295121
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 19879982
SIC: 2834 Pharmaceutical Preparations